Probiomedica is an innovative startup that focuses on creating advanced health devices by integrating engineering, biology, photonics, and robotics. With the slogan "Probiomedica develops innovative health devices using engineering, biology, photonics, and robotics," the company is committed to pioneering cutting-edge technologies for healthcare and personal well-being. Specifically, Probiomedica places emphasis on photo-therapies, leveraging its expertise in photonics and robotics to drive groundbreaking research in biomedical device development. Founded in 2015, Probiomedica received a significant €71.43K grant investment on 01 January 2019 from EASME - EU Executive Agency for SMEs. Despite the lack of specific industry information and headquarters details, the company's dedication to leveraging multiple disciplines such as engineering, biology, photonics, and robotics underscores its commitment to pioneering innovation in the healthcare sector. This recent investment marks a significant milestone for Probiomedica, providing the necessary resources to further its research and development efforts.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | €71.43K | 1 | EASME - EU Executive Agency for SMEs | 01 Jan 2019 |
No recent news or press coverage available for Probiomedica.